Exact Mass: 433.1460048
Exact Mass Matches: 433.1460048
Found 500 metabolites which its exact mass value is equals to given mass value 433.1460048
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Pelargonidin 3-glucoside
[C21H21O10]+ (433.11346660000004)
Acquisition and generation of the data is financially supported in part by CREST/JST.
N-acetylaspartylglutamylglutamic acid
C16H23N3O11 (433.13325280000004)
Meleagrine
C23H23N5O4 (433.17499580000003)
An indole alkaloid with a heterotetracyclic skeleton isolated from Penicillium oxalicum.
Pelargonidin 3-galactoside
C21H21O10+ (433.11346660000004)
Pelargonidin 3-galactoside is found in black chokeberry. Pelargonidin 3-galactoside is found in strawberry anthocyanin pigments used as fruit material in jam processing. Found in strawberry anthocyanin pigments used as fruit material in jam processing.
Cyanidin 3-rhamnoside
C21H21O10+ (433.11346660000004)
Cyanidin 3-rhamnoside is found in blackcurrant. Cyanidin 3-rhamnoside is isolated from various plant species, e.g. Chamaecyparis sp. and Plumbago rosea [CCD]. Isolated from various plant subspecies, e.g. Chamaecyparis species and Plumbago rosea [CCD]. Cyanidin 3-rhamnoside is found in common pea and blackcurrant.
Luteolinidin 3-O-glucoside
C21H21O10+ (433.11346660000004)
Luteolinidin 3-O-glucoside is a polyphenol compound found in foods of plant origin (PMID: 20428313)
Pelargonidin 5-galactoside
C21H21O10 (433.11346660000004)
Pelargonidin 5-galactoside is found in beverages. Pelargonidin 5-galactoside is isolated from matara tea (Cassia auriculata).
Peonidin 3-arabinoside
C21H21O10 (433.11346660000004)
Peonidin 3-arabinoside is found in american cranberry. Peonidin 3-arabinoside is isolated from grapes and many other plant species.
Petunidin 3-arabinoside
C21H21O10 (433.11346660000004)
Isolated from Vaccinium subspecies and other plant subspecies Petunidin 3-arabinoside is found in many foods, some of which are strawberry, red raspberry, lingonberry, and summer grape. Petunidin 3-arabinoside is found in american cranberry. Petunidin 3-arabinoside is isolated from Vaccinium species and other plant species.
Isopeonidin 3-arabinoside
C21H21O10 (433.11346660000004)
Isopeonidin 3-arabinoside is a polyphenol metabolite detected in biological fluids (PMID: 20428313).
Isopeonidin 3-xyloside
C21H21O10 (433.11346660000004)
Isopeonidin 3-xyloside is a polyphenol metabolite detected in biological fluids (PMID: 20428313).
Peonidin 3-xyloside
C21H21O10+ (433.11346660000004)
Peonidin 3-xyloside is a polyphenol metabolite detected in biological fluids (PMID: 20428313). A polyphenol metabolite detected in biological fluids [PhenolExplorer]
Tolmetin glucuronide
Tolmetin glucuronide belongs to the family of Glucuronic Acid Derivatives. These are compounds containing a glucuronic acid moeity (or a derivative), which consists of a glucose moiety with the C6 carbon oxidized to a carboxylic acid.
4-Hydroxy-5-[3-(sulfooxy)phenyl]pentanoylcarnitine
4-hydroxy-5-[3-(sulfooxy)phenyl]pentanoylcarnitine is an acylcarnitine. More specifically, it is an 4-hydroxy-5-[3-(sulfooxy)phenyl]pentanoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 4-hydroxy-5-[3-(sulfooxy)phenyl]pentanoylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine 4-hydroxy-5-[3-(sulfooxy)phenyl]pentanoylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].
(2R)-1-[4-[1,3-Benzothiazol-2-yl(methyl)amino]piperidin-1-yl]-3-(3,4-difluorophenoxy)propan-2-ol
2-[6,8-Difluoro-9-[(4-methylsulfonylphenyl)methyl]-1,2,3,4-tetrahydrocarbazol-1-yl]acetic acid
C22H21F2NO4S (433.11592900000005)
Amustaline
D000970 - Antineoplastic Agents > D018906 - Antineoplastic Agents, Alkylating > D009588 - Nitrogen Mustard Compounds C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C2842 - DNA Binding Agent
Brexpiprazole
C25H27N3O2S (433.18238820000005)
D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents > D018491 - Dopamine Agonists C78272 - Agent Affecting Nervous System > C29710 - Antipsychotic Agent N - Nervous system > N05 - Psycholeptics > N05A - Antipsychotics D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents Brexpiprazole (OPC-34712), an atypical orally active antipsychotic agent, is a partial agonist of human 5-HT1A and dopamine D2L receptor with Kis of 0.12 nM and 0.3 nM, respectively. Brexpiprazole is also a 5-HT2A receptor antagonist with a Ki of 0.47 nM. Brexpiprazole also shows potent antagonist activity at human noradrenergic α1B (Ki=0.17 nM) and α2C receptors (Ki=0.59 nM)[1][2].
(2S)-2-[[4-[[(2R)-2-Amino-3-sulfanylpropyl]amino]-2-phenylbenzoyl]amino]-4-methylsulfanylbutanoic acid
C21H27N3O3S2 (433.14937520000007)
7-[(Gly-L-Phe-)Amino]-4-(trifluoromethyl)-2H-1-benzopyran-2-one
C21H18F3N3O4 (433.12493440000003)
2-Methyl-1-(2-methyl-3-(trifluoromethyl)benzyl)-6-morpholino-1H-benzo[d]imidazole-4-carboxylic acid
C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C2152 - Phosphatidylinositide 3-Kinase Inhibitor C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor D004791 - Enzyme Inhibitors > D047428 - Protein Kinase Inhibitors C274 - Antineoplastic Agent > C1742 - Angiogenesis Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor D000970 - Antineoplastic Agents
4-Nitrophenyl 4-(3-phenoxybenzyl)piperazine-1-carboxylate
C24H23N3O5 (433.16376280000003)
1-(2-Methyl-4-methoxyphenyl)-4-((2-hydroxyethyl)amino)-6-trifluoromethoxy-2,3-dihydropyrrolo(3,2-c)quinoline
D004791 - Enzyme Inhibitors > D054328 - Proton Pump Inhibitors
2-[(Acridin-9-ylamino)methyl]-4-[bis(2-chloroethyl)amino]butanoic acid
Sarpicillin
C21H27N3O5S (433.1671332000001)
D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D010406 - Penicillins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams
N-(((1-(2-(Diethylamino)ethyl)amino)-9-oxo-9H-thioxanthen-4-yl)methyl)methanesulfonamide
C21H27N3O3S2 (433.14937520000007)
5-Oxoheptyl glucosinolate
C14H27NO10S2 (433.10763219999995)
5-oxoheptyl glucosinolate is a member of the class of compounds known as thioglycosides. Thioglycosides are glycoside in which a sugar group is bonded through one carbon to another group via a S-glycosidic bond. 5-oxoheptyl glucosinolate is slightly soluble (in water) and a very weakly acidic compound (based on its pKa). 5-oxoheptyl glucosinolate can be found in capers, which makes 5-oxoheptyl glucosinolate a potential biomarker for the consumption of this food product.
Peonidin 3-arabinoside
C21H21O10 (433.11346660000004)
Pelargonidin 5-galactoside
C21H21O10 (433.11346660000004)
Fenfangjine G
C22H27NO8 (433.17365820000003)
Pelargonidin 3-O-beta-D-galactopyranoside
C21H21O10 (433.11346660000004)
callistephin
C21H21O10 (433.11346660000004)
Cyanidin 3-rhamnoside
C21H21O10 (433.11346660000004)
Nitrile,1-O-beta-rutinoside-glucopyranoside,penta-Ac-1,4-Dihydroxy-2-cyclopentene-1-carboxylic acid
C18H27NO11 (433.15840319999995)
(1R)-(4-hydroxybenzyl)-7-hydroxyl-8-O-beta-D-glucopyranosyl-1,2,3,4-tetrahydroisoquinoline
C22H27NO8 (433.17365820000003)
Ala Asn Asp Asp
Dihydrozeatin riboside-5-monophosphate sodium salt
Cyanidin-3-O-rhamnoside
[C21H21O10]+ (433.11346660000004)
Annotation level-1 Acquisition and generation of the data is financially supported in part by CREST/JST.
Peonidin-3-O-alpha-arabinopyranoside
[C21H21O10]+ (433.11346660000004)
Acquisition and generation of the data is financially supported in part by CREST/JST.
12-[(2,4-dimethoxyphenyl)carbonyl]-6a,6b,10,11,11a,12-hexahydro-8,11-epoxyoxepino[4,5:3,4]pyrrolo[1,2-a]quinolin-7(8H)-one
relative retention time with respect to 9-anthracene Carboxylic Acid is 1.276 relative retention time with respect to 9-anthracene Carboxylic Acid is 1.275 relative retention time with respect to 9-anthracene Carboxylic Acid is 1.279
[(7R)-5-chloro-3-[(1E,3E,5S)-3,5-dimethylhepta-1,3-dienyl]-2-(2-hydroxyethyl)-7-methyl-6,8-dioxoisoquinolin-7-yl] acetate
C23H28ClNO5 (433.1655908000001)
C23H23N5O4_(3Z)-6-Hydroxy-3-(1H-imidazol-5-ylmethylene)-12-methoxy-7a-(2-methyl-3-buten-2-yl)-7a,12-dihydro-1H,5H-imidazo[1,2:1,2]pyrido[2,3-b]indole-2,5(3H)-dione
C23H23N5O4 (433.17499580000003)
pelargonidin-3-O-glucoside
[C21H21O10]+ (433.11346660000004)
Annotation level-1
[(7R)-5-chloro-3-[(1E,3E,5S)-3,5-dimethylhepta-1,3-dienyl]-2-(2-hydroxyethyl)-7-methyl-6,8-dioxoisoquinolin-7-yl] acetate [IIN-based on: CCMSLIB00000846974]
C23H28ClNO5 (433.1655908000001)
[(7R)-5-chloro-3-[(1E,3E,5S)-3,5-dimethylhepta-1,3-dienyl]-2-(2-hydroxyethyl)-7-methyl-6,8-dioxoisoquinolin-7-yl] acetate [IIN-based: Match]
C23H28ClNO5 (433.1655908000001)
Ala Asp Asp Asn
Ala Asp Asn Asp
Ala Asp Gln Thr
C16H27N5O9 (433.18086919999996)
Ala Asp Thr Gln
C16H27N5O9 (433.18086919999996)
Ala Glu Asn Thr
C16H27N5O9 (433.18086919999996)
Ala Glu Gln Ser
C16H27N5O9 (433.18086919999996)
Ala Glu Ser Gln
C16H27N5O9 (433.18086919999996)
Ala Glu Thr Asn
C16H27N5O9 (433.18086919999996)
Ala Asn Glu Thr
C16H27N5O9 (433.18086919999996)
Ala Asn Thr Glu
C16H27N5O9 (433.18086919999996)
Ala Gln Asp Thr
C16H27N5O9 (433.18086919999996)
Ala Gln Glu Ser
C16H27N5O9 (433.18086919999996)
Ala Gln Ser Glu
C16H27N5O9 (433.18086919999996)
Ala Gln Thr Asp
C16H27N5O9 (433.18086919999996)
Ala Ser Glu Gln
C16H27N5O9 (433.18086919999996)
Ala Ser Gln Glu
C16H27N5O9 (433.18086919999996)
Ala Thr Asp Gln
C16H27N5O9 (433.18086919999996)
Ala Thr Glu Asn
C16H27N5O9 (433.18086919999996)
Ala Thr Asn Glu
C16H27N5O9 (433.18086919999996)
Ala Thr Gln Asp
C16H27N5O9 (433.18086919999996)
Mefenamic acid Metabolite (b-D-Glucopyranuronic acid, 1-[2-[[3-(hydroxymethyl)-2-methylphenyl]amino]
Cys Asn Pro Thr
Cys Asn Thr Pro
Cys Pro Asn Thr
Cys Pro Gln Ser
Cys Pro Ser Gln
Cys Pro Thr Asn
Cys Gln Pro Ser
Cys Gln Ser Pro
Cys Ser Pro Gln
Cys Ser Gln Pro
Cys Thr Asn Pro
Cys Thr Pro Asn
Asp Ala Asp Asn
Asp Ala Asn Asp
Asp Ala Gln Thr
C16H27N5O9 (433.18086919999996)
Asp Ala Thr Gln
C16H27N5O9 (433.18086919999996)
Asp Asp Ala Asn
Asp Asp Gly Lys
C16H27N5O9 (433.18086919999996)
Asp Asp Gly Gln
Asp Asp Lys Gly
C16H27N5O9 (433.18086919999996)
Asp Asp Asn Ala
Asp Asp Gln Gly
Asp Glu Gly Asn
Asp Glu Asn Gly
Asp Gly Asp Lys
C16H27N5O9 (433.18086919999996)
Asp Gly Asp Gln
Asp Gly Glu Asn
Asp Gly Gly Trp
Asp Gly Lys Asp
C16H27N5O9 (433.18086919999996)
Asp Gly Asn Glu
Asp Gly Gln Asp
Asp Gly Trp Gly
Asp Lys Asp Gly
C16H27N5O9 (433.18086919999996)
Asp Lys Gly Asp
C16H27N5O9 (433.18086919999996)
Asp Asn Ala Asp
Asp Asn Asp Ala
Asp Asn Glu Gly
Asp Asn Gly Glu
Asp Asn Ser Val
C16H27N5O9 (433.18086919999996)
Asp Asn Val Ser
C16H27N5O9 (433.18086919999996)
Asp Gln Ala Thr
C16H27N5O9 (433.18086919999996)
Asp Gln Asp Gly
Asp Gln Gly Asp
Asp Gln Thr Ala
C16H27N5O9 (433.18086919999996)
Asp Ser Asn Val
C16H27N5O9 (433.18086919999996)
Asp Ser Val Asn
C16H27N5O9 (433.18086919999996)
Asp Thr Ala Gln
C16H27N5O9 (433.18086919999996)
Asp Thr Gln Ala
C16H27N5O9 (433.18086919999996)
Asp Val Asn Ser
C16H27N5O9 (433.18086919999996)
Asp Val Ser Asn
C16H27N5O9 (433.18086919999996)
Asp Trp Gly Gly
Glu Ala Asn Thr
C16H27N5O9 (433.18086919999996)
Glu Ala Gln Ser
C16H27N5O9 (433.18086919999996)
Glu Ala Ser Gln
C16H27N5O9 (433.18086919999996)
Glu Ala Thr Asn
C16H27N5O9 (433.18086919999996)
Glu Asp Gly Asn
Glu Asp Asn Gly
Glu Gly Asp Asn
Glu Gly Asn Asp
Glu Gly Gln Thr
C16H27N5O9 (433.18086919999996)
Glu Gly Thr Gln
C16H27N5O9 (433.18086919999996)
Glu Asn Ala Thr
C16H27N5O9 (433.18086919999996)
Glu Asn Asp Gly
Glu Asn Gly Asp
Glu Asn Thr Ala
C16H27N5O9 (433.18086919999996)
Glu Gln Ala Ser
C16H27N5O9 (433.18086919999996)
Glu Gln Gly Thr
C16H27N5O9 (433.18086919999996)
Glu Gln Ser Ala
C16H27N5O9 (433.18086919999996)
Glu Gln Thr Gly
C16H27N5O9 (433.18086919999996)
Glu Ser Ala Gln
C16H27N5O9 (433.18086919999996)
Glu Ser Gln Ala
C16H27N5O9 (433.18086919999996)
Glu Thr Ala Asn
C16H27N5O9 (433.18086919999996)
Glu Thr Gly Gln
C16H27N5O9 (433.18086919999996)
Glu Thr Asn Ala
C16H27N5O9 (433.18086919999996)
Glu Thr Gln Gly
C16H27N5O9 (433.18086919999996)
Gly Asp Asp Lys
C16H27N5O9 (433.18086919999996)
Gly Asp Asp Gln
Gly Asp Glu Asn
Gly Asp Gly Trp
Gly Asp Lys Asp
C16H27N5O9 (433.18086919999996)
Gly Asp Asn Glu
Gly Asp Gln Asp
Gly Asp Trp Gly
Gly Glu Asp Asn
Gly Glu Asn Asp
Gly Glu Gln Thr
C16H27N5O9 (433.18086919999996)
Gly Glu Thr Gln
C16H27N5O9 (433.18086919999996)
Gly Gly Asp Trp
Gly Gly Trp Asp
Gly Lys Asp Asp
C16H27N5O9 (433.18086919999996)
Gly Asn Asp Glu
Gly Asn Glu Asp
Gly Gln Asp Asp
Gly Gln Glu Thr
C16H27N5O9 (433.18086919999996)
Gly Gln Thr Glu
C16H27N5O9 (433.18086919999996)
Gly Thr Glu Gln
C16H27N5O9 (433.18086919999996)
Gly Thr Gln Glu
C16H27N5O9 (433.18086919999996)
Gly Trp Asp Gly
Gly Trp Gly Asp
Lys Asp Asp Gly
C16H27N5O9 (433.18086919999996)
Lys Asp Gly Asp
C16H27N5O9 (433.18086919999996)
Lys Gly Asp Asp
C16H27N5O9 (433.18086919999996)
Asn Ala Asp Asp
Asn Ala Glu Thr
C16H27N5O9 (433.18086919999996)
Asn Ala Thr Glu
C16H27N5O9 (433.18086919999996)
Asn Cys Pro Thr
Asn Cys Thr Pro
Asn Asp Ala Asp
Asn Asp Asp Ala
Asn Asp Glu Gly
Asn Asp Gly Glu
Asn Asp Ser Val
C16H27N5O9 (433.18086919999996)
Asn Asp Val Ser
C16H27N5O9 (433.18086919999996)
Asn Glu Ala Thr
C16H27N5O9 (433.18086919999996)
Asn Glu Asp Gly
Asn Glu Gly Asp
Asn Glu Thr Ala
C16H27N5O9 (433.18086919999996)
Asn Gly Asp Glu
Asn Gly Glu Asp
Asn Pro Cys Thr
Asn Pro Thr Cys
Asn Ser Asp Val
C16H27N5O9 (433.18086919999996)
Asn Ser Val Asp
C16H27N5O9 (433.18086919999996)
Asn Thr Ala Glu
C16H27N5O9 (433.18086919999996)
Asn Thr Cys Pro
Asn Thr Glu Ala
C16H27N5O9 (433.18086919999996)
Asn Thr Pro Cys
Asn Val Asp Ser
C16H27N5O9 (433.18086919999996)
Asn Val Ser Asp
C16H27N5O9 (433.18086919999996)
Pro Cys Asn Thr
Pro Cys Gln Ser
Pro Cys Ser Gln
Pro Cys Thr Asn
Pro Asn Cys Thr
Pro Asn Thr Cys
Pro Gln Cys Ser
Pro Gln Ser Cys
Pro Ser Cys Gln
Pro Ser Gln Cys
Pro Thr Cys Asn
Pro Thr Asn Cys
Gln Ala Asp Thr
C16H27N5O9 (433.18086919999996)
Gln Ala Glu Ser
C16H27N5O9 (433.18086919999996)
Gln Ala Ser Glu
C16H27N5O9 (433.18086919999996)
Gln Ala Thr Asp
C16H27N5O9 (433.18086919999996)
Gln Cys Pro Ser
Gln Cys Ser Pro
Gln Asp Ala Thr
C16H27N5O9 (433.18086919999996)
Gln Asp Asp Gly
Gln Asp Gly Asp
Gln Asp Thr Ala
C16H27N5O9 (433.18086919999996)
Gln Glu Ala Ser
C16H27N5O9 (433.18086919999996)
Gln Glu Gly Thr
C16H27N5O9 (433.18086919999996)
Gln Glu Ser Ala
C16H27N5O9 (433.18086919999996)
Gln Glu Thr Gly
C16H27N5O9 (433.18086919999996)
Gln Gly Asp Asp
Gln Gly Glu Thr
C16H27N5O9 (433.18086919999996)
Gln Gly Thr Glu
C16H27N5O9 (433.18086919999996)
Gln Pro Cys Ser
Gln Pro Ser Cys
Gln Ser Ala Glu
C16H27N5O9 (433.18086919999996)
Gln Ser Cys Pro
Gln Ser Glu Ala
C16H27N5O9 (433.18086919999996)
Gln Ser Pro Cys
Gln Thr Ala Asp
C16H27N5O9 (433.18086919999996)
Gln Thr Asp Ala
C16H27N5O9 (433.18086919999996)
Gln Thr Glu Gly
C16H27N5O9 (433.18086919999996)
Gln Thr Gly Glu
C16H27N5O9 (433.18086919999996)
Ser Ala Glu Gln
C16H27N5O9 (433.18086919999996)
Ser Ala Gln Glu
C16H27N5O9 (433.18086919999996)
Ser Cys Pro Gln
Ser Cys Gln Pro
Ser Asp Asn Val
C16H27N5O9 (433.18086919999996)
Ser Asp Val Asn
C16H27N5O9 (433.18086919999996)
Ser Glu Ala Gln
C16H27N5O9 (433.18086919999996)
Ser Glu Gln Ala
C16H27N5O9 (433.18086919999996)
Ser Asn Asp Val
C16H27N5O9 (433.18086919999996)
Ser Asn Val Asp
C16H27N5O9 (433.18086919999996)
Ser Pro Cys Gln
Ser Pro Gln Cys
Ser Gln Ala Glu
C16H27N5O9 (433.18086919999996)
Ser Gln Cys Pro
Ser Gln Glu Ala
C16H27N5O9 (433.18086919999996)
Ser Gln Pro Cys
Ser Val Asp Asn
C16H27N5O9 (433.18086919999996)
Ser Val Asn Asp
C16H27N5O9 (433.18086919999996)
Thr Ala Asp Gln
C16H27N5O9 (433.18086919999996)
Thr Ala Glu Asn
C16H27N5O9 (433.18086919999996)
Thr Ala Asn Glu
C16H27N5O9 (433.18086919999996)
Thr Ala Gln Asp
C16H27N5O9 (433.18086919999996)
Thr Cys Asn Pro
Thr Cys Pro Asn
Thr Asp Ala Gln
C16H27N5O9 (433.18086919999996)
Thr Asp Gln Ala
C16H27N5O9 (433.18086919999996)
Thr Glu Ala Asn
C16H27N5O9 (433.18086919999996)
Thr Glu Gly Gln
C16H27N5O9 (433.18086919999996)
Thr Glu Asn Ala
C16H27N5O9 (433.18086919999996)
Thr Glu Gln Gly
C16H27N5O9 (433.18086919999996)
Thr Gly Glu Gln
C16H27N5O9 (433.18086919999996)
Thr Gly Gln Glu
C16H27N5O9 (433.18086919999996)
Thr Asn Ala Glu
C16H27N5O9 (433.18086919999996)
Thr Asn Cys Pro
Thr Asn Glu Ala
C16H27N5O9 (433.18086919999996)
Thr Asn Pro Cys
Thr Pro Cys Asn
Thr Pro Asn Cys
Thr Gln Ala Asp
C16H27N5O9 (433.18086919999996)
Thr Gln Asp Ala
C16H27N5O9 (433.18086919999996)
Thr Gln Glu Gly
C16H27N5O9 (433.18086919999996)
Thr Gln Gly Glu
C16H27N5O9 (433.18086919999996)
Val Asp Asn Ser
C16H27N5O9 (433.18086919999996)
Val Asp Ser Asn
C16H27N5O9 (433.18086919999996)
Val Asn Asp Ser
C16H27N5O9 (433.18086919999996)
Val Asn Ser Asp
C16H27N5O9 (433.18086919999996)
Val Ser Asp Asn
C16H27N5O9 (433.18086919999996)
Val Ser Asn Asp
C16H27N5O9 (433.18086919999996)
Trp Asp Gly Gly
Trp Gly Asp Gly
Trp Gly Gly Asp
N-(3-pyridyl)-Indomethacin amide
C24H20ClN3O3 (433.11931200000004)
Luteolinidin 3-O-glucoside
C21H21O10+ (433.11346660000004)
Fragarin
C21H21O10+ (433.11346660000004)
Petunidin 3-arabinoside
C21H21O10 (433.11346660000004)
Isopeonidin 3-arabinoside
C21H21O10 (433.11346660000004)
Isopeonidin 3-xyloside
C21H21O10 (433.11346660000004)
Peonidin 3-xyloside
C21H21O10 (433.11346660000004)
Tolmetin glucuronide
6-(methylamino)hexane-1,2,3,4,5-pentol,4-(2H-tetrazol-5-yl)tetrazolo[1,5-a]quinoline
1H-Pyrazole-4-carboxamide,5-chloro-N-[2-[(3,7-dimethyl-2-quinolinyl)amino]ethyl]-3-methyl-1-phenyl-(9CI)
4-BROMO-N-DODECYL-1-HYDROXY-2-NAPHTHALENECARBOXAMIDE
3-[p-[(2-chloro-4-nitrophenyl)azo]-N-phenethylanilino]propiononitrile
C23H20ClN5O2 (433.13054500000004)
(4R,12aS)-N-(2,4-Difluorobenzyl)-7-Methoxy-4-Methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-[1,3]oxazino[3,2-d]pyrido[1,2-a]pyrazine-9-carboxamide
Sarpicillin
C21H27N3O5S (433.1671332000001)
D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D010406 - Penicillins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams
3-[[4-(diethylamino)phenyl]azo]-1,2-dimethyl-1H-indazolium methyl sulphate
C20H27N5O4S (433.1783662000001)
Pyrrolidinium,1,1-diethyl-3-[(2-hydroxy-2,2-diphenylacetyl)oxy]-, bromide (1:1)
4-Aminophenyl-beta-D-lactopyranoside
C18H27NO11 (433.15840319999995)
9-(4-bromophenyl)-3,6-di-tert-butyl-9H-carbazole
C26H28BrN (433.14049880000005)
1H-Benzimidazole,5,6-dimethyl-1-[[4-(1-piperidinylsulfonyl)phenyl]sulfonyl]-(9CI)
C20H23N3O4S2 (433.11299180000003)
(R)-N-Fmoc-3-amino-4-(phenylthio)butanoic Acid
C25H23NO4S (433.13477180000007)
Thiourea, N-[2-(5,6-dimethyl-1H-benzimidazol-2-yl)ethyl]-N-(4-fluorophenyl)-N-(3-pyridinylmethyl)- (9CI)
2-[2-[4-[(2-chloroethyl)methylamino]phenyl]vinyl]-1,3,3-trimethyl-3H-indolium dihydrogen phosphate
C22H27ClN2O3P++ (433.1447732000001)
9-AMino-(9-deoxy)epi-dihydroquinine trihydrochloride
Pipenzolate Bromide
C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent > C29704 - Antimuscarinic Agent
(S)-(4-(3-(BENZYLOXY)-2-(((BENZYLOXY)CARBONYL)AMINO)-3-OXOPROPYL)PHENYL)BORONIC ACID
Methyl (3R,4S)-1-(4-fluorophenyl)-2-oxo-4-[4-(phenylmethoxy)phenyl]-3-azetidinepropanoate
Hydroxychloroquine sulfate
C18H28ClN3O5S (433.1438108000001)
D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000981 - Antiprotozoal Agents C254 - Anti-Infective Agent > C276 - Antiparasitic Agent > C277 - Antiprotozoal Agent COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials D018501 - Antirheumatic Agents D004791 - Enzyme Inhibitors Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
8-(2-Chloro-3,4,5-trimethoxy-benzyl)-2-fluoro-9-pent-4-ylnyl-9H-purin-6-ylamine
Fluvastatin sodium
C24H25FNNaO4 (433.16652220000003)
C78276 - Agent Affecting Digestive System or Metabolism > C29703 - Antilipidemic Agent C471 - Enzyme Inhibitor > C1655 - HMG-CoA Reductase Inhibitor (3S,5R)-Fluvastatin sodium ((3S,5R)-XU 62-320) is the (3S,5R)-enantiomer?of Fluvastatin. Fluvastatin is a first fully synthetic, competitive?HMG-CoA reductase?inhibitor with an IC50?of 8 nM. Fluvastatin protects vascular smooth muscle cells against oxidative stress through the Nrf2-dependent antioxidant pathway[1].
Lubeluzole
D002491 - Central Nervous System Agents > D018696 - Neuroprotective Agents C26170 - Protective Agent > C1509 - Neuroprotective Agent D002317 - Cardiovascular Agents D020011 - Protective Agents
(4-Nitrophenyl) 4-[(3-phenoxyphenyl)methyl]piperazine-1-carboxylate
C24H23N3O5 (433.16376280000003)
JZL195 is a selective and efficacious dual fatty acid amide hydrolase (FAAH) and monoacylglycerol lipase (MAGL) inhibitor with IC50s of 2 and 4 nM, respectively[1].
N-(((1-(2-(Diethylamino)ethyl)amino)-9-oxo-9H-thioxanthen-4-yl)methyl)methanesulfonamide
C21H27N3O3S2 (433.14937520000007)
1-(4-(Benzo[d]thiazol-2-yl(methyl)amino)piperidin-1-yl)-3-(3,4-difluorophenoxy)propan-2-ol
(3r,5s)-Fluvastatin sodium
C24H25FNNaO4 (433.16652220000003)
C - Cardiovascular system > C10 - Lipid modifying agents > C10A - Lipid modifying agents, plain > C10AA - Hmg coa reductase inhibitors (3R,5S)-Fluvastatin ((3R,5S)-XU 62-320) sodium is the 3R,5S-isomer Fluvastatin. Fluvastatin (XU 62-320 free acid) is a first fully synthetic, competitive HMG-CoA reductase inhibitor with an IC50 of 8 nM. Fluvastatin protects vascular smooth muscle cells against oxidative stress through the Nrf2-dependent antioxidant pathway[1][2][3].
(2S)-2-[[4-[[(2R)-2-Amino-3-sulfanylpropyl]amino]-2-phenylbenzoyl]amino]-4-methylsulfanylbutanoic acid
C21H27N3O3S2 (433.14937520000007)
N-(3-chloropyridin-2-yl)-N-[(3R)-piperidin-3-yl]-4-(3H-[1,2,3]triazolo[4,5-b]pyridin-3-yl)benzamide
C22H20ClN7O (433.14177800000004)
N-(2,4-dimethoxyphenyl)-2-[1-(3,4-dimethylphenyl)-4-oxo-5-pyrazolo[3,4-d]pyrimidinyl]acetamide
C23H23N5O4 (433.17499580000003)
5-[(3,4-Dimethoxyphenyl)-[4-(2-hydroxyethyl)-1-piperazinyl]methyl]-2-methyl-6-thiazolo[3,2-b][1,2,4]triazolol
C20H27N5O4S (433.1783662000001)
[[N-(2,5-Diamino-6-hydroxy-pyrimidin-4-YL)-ureayl]-phen-4-YL]-carbonyl-glutamic acid
Brexpiprazole
C25H27N3O2S (433.18238820000005)
D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents > D018491 - Dopamine Agonists C78272 - Agent Affecting Nervous System > C29710 - Antipsychotic Agent N - Nervous system > N05 - Psycholeptics > N05A - Antipsychotics D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents Brexpiprazole (OPC-34712), an atypical orally active antipsychotic agent, is a partial agonist of human 5-HT1A and dopamine D2L receptor with Kis of 0.12 nM and 0.3 nM, respectively. Brexpiprazole is also a 5-HT2A receptor antagonist with a Ki of 0.47 nM. Brexpiprazole also shows potent antagonist activity at human noradrenergic α1B (Ki=0.17 nM) and α2C receptors (Ki=0.59 nM)[1][2].
Petunidin 3-arabinoside
C21H21O10+ (433.11346660000004)
Isolated from Vaccinium subspecies and other plant subspecies Petunidin 3-arabinoside is found in many foods, some of which are strawberry, red raspberry, lingonberry, and summer grape. Petunidin 3-arabinoside is found in american cranberry. Petunidin 3-arabinoside is isolated from Vaccinium species and other plant species.
(2S)-2-[[4-[[(2R)-2-Amino-3-sulfanylpropyl]amino]-2-phenylbenzoyl]amino]-4-methylsulfanylbutanoic acid
C21H27N3O3S2 (433.14937520000007)
(3Z)-3-[(2E,4E,6R)-1-hydroxy-6-[(2S,7R,8R)-2-(hydroxymethyl)-1,7-dimethyl-5-oxo-3,9,10-trioxatricyclo[4.3.1.02,4]decan-8-yl]-4-methylhepta-2,4-dienylidene]pyrrolidine-2,4-dione
C22H27NO8 (433.17365820000003)
4-Hydroxy-5-[3-(sulfooxy)phenyl]pentanoylcarnitine
2-[3,7-Dihydroxy-2-(4-hydroxyphenyl)chromenylium-5-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol
C21H21O10+ (433.11346660000004)
(3E,7aS,12aR)-6-hydroxy-3-(1H-imidazol-4-ylmethylidene)-12-methoxy-7a-(2-methylbut-3-en-2-yl)-7a,12-dihydro-1H,5H-imidazo[1,2:1,2]pyrido[2,3-b]indole-2,5(3H)-dione
C23H23N5O4 (433.17499580000003)
4-[3-[5-Oxo-7-(1-piperazinyl)-[1,3,4]thiadiazolo[3,2-a]pyrimidin-2-yl]phenyl]benzoic acid
C22H19N5O3S (433.1208544000001)
N-{4-[(1H-benzotriazol-1-ylacetyl)(thiophen-3-ylmethyl)amino]phenyl}-2-methylpropanamide
2-[4-[(4-Chlorophenyl)methoxy]phenyl]-5-[3-(1-imidazolyl)propylamino]-4-oxazolecarbonitrile
C23H20ClN5O2 (433.13054500000004)
N-[3-[(2-methoxyphenyl)sulfamoyl]phenyl]-2-quinolinecarboxamide
C23H19N3O4S (433.1096214000001)
bulbisine Trifluoroacetic acid
C19H22F3NO7 (433.13482980000003)
A natural product found in Crinum asiaticum var. sinicum.
4-chloro-N-[2-(1H-indol-3-yl)-1-(6,7,8,9-tetrahydro-5H-[1,2,4]triazolo[4,3-a]azepin-3-yl)ethyl]benzamide
3-(3,4,5-Trimethoxyphenyl)propanoic acid [2-(3,5-dimethoxyanilino)-2-oxoethyl] ester
C22H27NO8 (433.17365820000003)
3-(Diethylsulfamoyl)benzoic acid [2-(2,3-dihydro-1,4-benzodioxin-6-yl)-2-oxoethyl] ester
C21H23NO7S (433.11951680000004)
2-[[7-(4-Methoxyphenyl)-5-phenyl-4-pyrrolo[2,3-d]pyrimidinyl]thio]propanoic acid ethyl ester
3-[2-[(1,5-Dimethyl-3-oxo-2-phenyl-4-pyrazolyl)amino]-2-oxoethyl]-4-oxo-1-phthalazinecarboxylic acid
C22H19N5O5 (433.13861240000006)
[1-[1-[4-(difluoromethoxy)phenyl]-2,5-dimethylpyrrol-3-yl]-1-oxopropan-2-yl] 6-oxo-4,5-dihydro-1H-pyridazine-3-carboxylate
7-[(2-Chloro-6-fluorophenyl)methyl]-1,3-dimethyl-8-[(3-methyl-1-piperidinyl)methyl]purine-2,6-dione
2,4,4,6-tetrahydroxychalcone 4-O-beta-D-glucoside(1-)
C21H21O10- (433.11346660000004)
5-Ethyl-2-[[[3-(4-morpholinyl)-4-nitrophenyl]-oxomethyl]amino]-3-thiophenecarboxylic acid ethyl ester
C20H23N3O6S (433.13074980000005)
1-(4-methylphenyl)-3-[[2-(4-methylphenyl)-1,3-dioxo-7,7a-dihydro-3aH-octahydro-1H-4,7-epoxyisoindol-4-yl]methyl]thiourea
2-[(1R,3S,4aS,9aR)-6-(benzenesulfonamido)-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]acetic acid methyl ester
C21H23NO7S (433.11951680000004)
N-(2,5-dimethoxyphenyl)sulfonyl-N-(4-methoxyphenyl)cyclohexanecarboxamide
C22H27NO6S (433.1559002000001)
2-(4-chlorophenoxy)-N-[3-(dimethylamino)propyl]-N-(4-methoxy-1,3-benzothiazol-2-yl)acetamide
C21H24ClN3O3S (433.12268240000003)
4-[2-Benzofuranyl(oxo)methyl]-1-[2-(4-morpholinyl)ethyl]-5-(3-pyridinyl)pyrrolidine-2,3-dione
C24H23N3O5 (433.16376280000003)
4-[4-[(1S,5R)-3-(4-fluorophenyl)sulfonyl-3,6-diazabicyclo[3.1.1]heptan-7-yl]phenyl]benzonitrile
C24H20FN3O2S (433.12601920000003)
(2S,3S,3aR,9bR)-7-(4-fluorophenyl)-3-(hydroxymethyl)-1-methyl-6-oxo-N-phenyl-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizine-2-carboxamide
(2R,3R,3aS,9bS)-7-(4-fluorophenyl)-3-(hydroxymethyl)-1-methyl-6-oxo-N-phenyl-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizine-2-carboxamide
N-[(2R,3S,6S)-6-[2-[[(4-chloroanilino)-oxomethyl]amino]ethyl]-2-(hydroxymethyl)-3-oxanyl]-2-pyrazinecarboxamide
C20H24ClN5O4 (433.15167340000005)
N-[(2R,3R,6S)-6-[2-[[(4-chloroanilino)-oxomethyl]amino]ethyl]-2-(hydroxymethyl)-3-oxanyl]-2-pyrazinecarboxamide
C20H24ClN5O4 (433.15167340000005)
2-[(2R,3S,6S)-3-[[(2,5-difluoroanilino)-oxomethyl]amino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]-N-(4-pyrimidinylmethyl)acetamide
2-[(2S,3S,6R)-3-[[(2,5-difluoroanilino)-oxomethyl]amino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]-N-(4-pyrimidinylmethyl)acetamide
2-[(2R,3R,6R)-3-[[(2,5-difluoroanilino)-oxomethyl]amino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]-N-(4-pyrimidinylmethyl)acetamide
N-[(2R,3S,6R)-6-[2-[[(4-chloroanilino)-oxomethyl]amino]ethyl]-2-(hydroxymethyl)-3-oxanyl]-2-pyrazinecarboxamide
C20H24ClN5O4 (433.15167340000005)
(1R,2aS,8bS)-2-[(2-chlorophenyl)methyl]-1-(hydroxymethyl)-N-phenyl-1,2a,3,8b-tetrahydroazeto[2,3-c]quinoline-4-carboxamide
(1R,2aR,8bR)-2-[(2-chlorophenyl)methyl]-1-(hydroxymethyl)-N-phenyl-1,2a,3,8b-tetrahydroazeto[2,3-c]quinoline-4-carboxamide
(1R,9S,10S,11S)-N-benzyl-5-(3-fluorophenyl)-10-(hydroxymethyl)-6-oxo-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxamide
[(2S,3R)-1-[(4-chlorophenyl)methyl]-2-(hydroxymethyl)-3-phenyl-1,6-diazaspiro[3.3]heptan-6-yl]-(3-pyridinyl)methanone
[(2S,3S)-1-[(4-chlorophenyl)methyl]-2-(hydroxymethyl)-3-phenyl-1,6-diazaspiro[3.3]heptan-6-yl]-(3-pyridinyl)methanone
N-[(2R,3R,6R)-6-[2-[[(4-chloroanilino)-oxomethyl]amino]ethyl]-2-(hydroxymethyl)-3-oxanyl]-2-pyrazinecarboxamide
C20H24ClN5O4 (433.15167340000005)
N-[(2S,3S,6R)-6-[2-[[(4-chloroanilino)-oxomethyl]amino]ethyl]-2-(hydroxymethyl)-3-oxanyl]-2-pyrazinecarboxamide
C20H24ClN5O4 (433.15167340000005)
N-[(2S,3S,6S)-6-[2-[[(4-chloroanilino)-oxomethyl]amino]ethyl]-2-(hydroxymethyl)-3-oxanyl]-2-pyrazinecarboxamide
C20H24ClN5O4 (433.15167340000005)
2-[(2S,3R,6R)-3-[[(2,5-difluoroanilino)-oxomethyl]amino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]-N-(4-pyrimidinylmethyl)acetamide
2-[(2S,3R,6S)-3-[[(2,5-difluoroanilino)-oxomethyl]amino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]-N-(4-pyrimidinylmethyl)acetamide
2-[(2R,3S,6R)-3-[[(2,5-difluoroanilino)-oxomethyl]amino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]-N-(4-pyrimidinylmethyl)acetamide
2-[(2R,3R,6S)-3-[[(2,5-difluoroanilino)-oxomethyl]amino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]-N-(4-pyrimidinylmethyl)acetamide
N-[(2S,3R,6S)-6-[2-[[(4-chloroanilino)-oxomethyl]amino]ethyl]-2-(hydroxymethyl)-3-oxanyl]-2-pyrazinecarboxamide
C20H24ClN5O4 (433.15167340000005)
N-[(2S,3R,6R)-6-[2-[[(4-chloroanilino)-oxomethyl]amino]ethyl]-2-(hydroxymethyl)-3-oxanyl]-2-pyrazinecarboxamide
C20H24ClN5O4 (433.15167340000005)
(1S,2aR,8bR)-2-[(2-chlorophenyl)methyl]-1-(hydroxymethyl)-N-phenyl-1,2a,3,8b-tetrahydroazeto[2,3-c]quinoline-4-carboxamide
(1S,2aS,8bS)-2-[(2-chlorophenyl)methyl]-1-(hydroxymethyl)-N-phenyl-1,2a,3,8b-tetrahydroazeto[2,3-c]quinoline-4-carboxamide
(1S,9R,10R,11R)-N-benzyl-5-(3-fluorophenyl)-10-(hydroxymethyl)-6-oxo-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxamide
cyclobutyl-[(1S)-1-(hydroxymethyl)-7-methoxy-1-methylsulfonyl-2-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,3-azetidine]yl]methanone
C21H27N3O5S (433.1671332000001)
[(2R,3R)-1-[(4-chlorophenyl)methyl]-2-(hydroxymethyl)-3-phenyl-1,6-diazaspiro[3.3]heptan-6-yl]-(3-pyridinyl)methanone
cyclobutyl-[(1R)-1-(hydroxymethyl)-7-methoxy-1-methylsulfonyl-2-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,3-azetidine]yl]methanone
C21H27N3O5S (433.1671332000001)
5-(3,4-Dimethoxyphenyl)-4-(furan-2-carbonyl)-1-(2-phenylethyl)pyrrolidine-2,3-dione
Peonidin-3-O-alpha-arabinopyranoside
C21H21O10+ (433.11346660000004)
L-670,596
C22H21F2NO4S (433.11592900000005)
Pelargonidin 3-O-beta-D-glucoside
C21H21O10 (433.11346660000004)
An anthocyanin cation consisting of pelargonidin having a beta-D-glucosyl residue attached at the 3-hydroxy position.
BAY-545
C18H22F3N3O4S (433.1283048000001)
BAY-545 is a potent and selective A2B adenosine receptor antagonist, with an IC50 of 59 nM. BAY-545 also exhibits IC50s of 66, 400, 280 nM for human, mouse, rat A2B adenosine receptor in cells, respectively, and a Ki of 97 nM for human A2B adenosine receptor, with more selectivity over A1, A2A, and A3 adenosine receptor[1].
Fluvastatin (sodium)
C24H25FNNaO4 (433.16652220000003)
Fluvastatin sodium (XU 62320) is a first fully synthetic, competitive HMG-CoA reductase inhibitor with an IC50 of 8 nM. Fluvastatin sodium protects vascular smooth muscle cells against oxidative stress through the Nrf2-dependent antioxidant pathway[1][2][3].
G907
C26H24ClNO3 (433.14446240000007)
G907 is a selective antagonist of ATP-binding cassette (ABC) transporter MsbA with anti-microbial activity. G907 inhibits E. coli MsbA with an IC50 value of 18 nM. G907 traps MsbA in an inward-facing, lipopolysaccharide-bound conformation by wedging into an architecturally conserved transmembrane pocket[1][2].
Izilendustat
C22H28ClN3O4 (433.1768238000001)
Izilendustat is a potent inhibitor of prolyl hydroxylase which can stabilize hypoxia inducible factor- 1 alpha (HIF- lα) and hypoxia inducible factor-2 (HIF-2). Izilendustat has the potential for researching diseases that relate to the body’s inmmune response like colitis and other inflammatory bowel diseases (extracted from patent WO2011057115A1 and WO2011057121A1)[1][1].
PHT-7.3
PHT-7.3 is a selective inhibitor of connector enhancer of kinase suppressor of Ras 1 (Cnk1) pleckstrin homology (PH) domain (Kd=4.7 μM). PHT-7.3 inhibits mut-KRas, but not wild-type KRas cancer cell and tumor growth and signaling. PHT-7.3 has antitumor activity[1].
[(2r,3r,4r,5s)-3,4-dihydroxy-5-(6-{[(3s)-4-hydroxy-3-methylbutyl]amino}purin-9-yl)oxolan-2-yl]methoxyphosphonic acid
(7s)-5-chloro-3-[(1e,3e,5r)-3,5-dimethylhepta-1,3-dien-1-yl]-2-(2-hydroxyethyl)-7-methyl-6,8-dioxoisoquinolin-7-yl acetate
C23H28ClNO5 (433.1655908000001)
(1s,8r,9r,12s,13r)-12-(acetyloxy)-3,8-dihydroxy-4,11-dimethoxy-17-azatetracyclo[7.5.3.0¹,¹⁰.0²,⁷]heptadeca-2(7),3,5,10-tetraen-13-yl acetate
C22H27NO8 (433.17365820000003)
11-(5-{[(3-carboxy-1-hydroxy-3-methylpropylidene)amino]carbonyl}-4-oxopyran-2-yl)undeca-8,10-dienoic acid
C22H27NO8 (433.17365820000003)
(1r,4s)-4-hydroxy-1-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-({[(2r,3s,4s,5s,6r)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}methyl)oxan-2-yl]oxy}cyclopent-2-ene-1-carbonitrile
C18H27NO11 (433.15840319999995)
5-({4,5-bis[(4-methoxyphenyl)methyl]imidazol-2-ylidene}amino)-3-methylimidazole-2,4-diol
C23H23N5O4 (433.17499580000003)
[(7r,7as)-7-{[(2r,3r)-3-chloro-2-hydroxy-2-methylbutanoyl]oxy}-5,6,7,7a-tetrahydro-3h-pyrrolizin-1-yl]methyl (2s)-2-hydroxy-2-[(1r)-1-hydroxyethyl]-3-methylbutanoate
(4z)-5-hydroxy-4-[(2e,4e,6r)-1-hydroxy-6-[(1s,2s,4r,6s,7r,8r)-2-(hydroxymethyl)-1,7-dimethyl-5-oxo-3,9,10-trioxatricyclo[4.3.1.0²,⁴]decan-8-yl]-4-methylhepta-2,4-dien-1-ylidene]-2h-pyrrol-3-one
C22H27NO8 (433.17365820000003)
(2z)-3-[(2r,3's,3'as,8'ar)-3'-ethyl-4-methyl-4',5-dioxo-3',3'a,6',7',8',8'a-hexahydrospiro[furan-2,2'-furo[3,2-c]azepin]-5'-yl]-3-[(2s,4s)-4-methyl-5-oxooxolan-2-yl]prop-2-enoic acid
C22H27NO8 (433.17365820000003)